2013
DOI: 10.1016/j.oraloncology.2013.03.314
|View full text |Cite
|
Sign up to set email alerts
|

Pp071

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Lymphopenia and immunocytotoxicity are also associated with metastasis (Mlecnik et al, 2016). FAK reduces lymphocyte toxicity and affects lymphatic vessel formation (Morita et al, 2015). Among the known lymphangiogenic factors, vascular endothelial growth factor-C (VEGF-C) is the best characterized and recognized as a major regulator of lymphangiogenesis.…”
Section: Lymphangiogenesismentioning
confidence: 99%
“…Lymphopenia and immunocytotoxicity are also associated with metastasis (Mlecnik et al, 2016). FAK reduces lymphocyte toxicity and affects lymphatic vessel formation (Morita et al, 2015). Among the known lymphangiogenic factors, vascular endothelial growth factor-C (VEGF-C) is the best characterized and recognized as a major regulator of lymphangiogenesis.…”
Section: Lymphangiogenesismentioning
confidence: 99%
“…In addition, both COX-2 and PGE2 regulate tumor angiogenesis by modulating VEGF or directly influencing endothelial cell proliferation (59). COX-2 expression is also correlated with lymph node metastasis and disease progression in nasopharyngeal carcinoma (NPC), and co-expression of COX-2/ VEGF-C in OSCC has been associated with the generation of lymphatic vessels (60,61). Furthermore, PGE2 promotes the maturation of regulatory T cells (Tregs) and facilitates the recruitment of MDSCs to the tumor tissues, which suppresses the anti-tumor immune response and promotes tumor growth (62).…”
Section: Targeting the Cox-2 Pathwaymentioning
confidence: 99%